Jan 16
|
Immuron achieves record half yearly Travelan® sales
|
Dec 22
|
Immuron Clinical Trials Update
|
Dec 4
|
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
|
Nov 28
|
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
|
Aug 14
|
Immuron to present at the Military Health System Research Symposium
|